FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014335798> ?p ?o ?g. }

• W2014335798 endingPage "6492" @default.
• W2014335798 startingPage "6485" @default.
• W2014335798 abstract "Post-infectious immunity to respiratory syncytial virus (RSV) infection results in limited protection as evidenced by the high rate of infant hospitalization in the face of high titer, maternally derived RSV-specific antibodies. By contrast, RSV fusion (F) glycoprotein antigenic site II humanized monoclonal antibodies, palivizumab and motavizumab, have been shown to reduce RSV-related hospitalization in infants. Immunogenicity and efficacy studies were conducted in cotton rats comparing a recombinant RSV F nanoparticle vaccine with palivizumab and controlled with live RSV virus intranasal immunization and, formalin inactivated RSV vaccine. Active immunization with RSV F nanoparticle vaccine containing an alum adjuvant induced serum levels of palivizumab competing antibody (PCA) greater than passive administration of 15 mg/kg palivizumab (human prophylactic dose) in cotton rats and neutralized RSV-A and RSV-B viruses. Immunization prevented detectable RSV replication in the lungs and, unlike passive administration of palivizumab, in the nasal passage of challenged cotton rats. Histology of lung tissues following RSV challenge showed no enhanced disease in the vaccinated groups in contrast to formalin inactivated ‘Lot 100’ vaccine. Passive intramuscular administration of RSV F vaccine-induced immune sera one day prior to challenge of cotton rats reduced viral titers by 2 or more log10 virus per gram of lung and nasal tissue and at doses less than palivizumab. A recombinant RSV F nanoparticle vaccine protected lower and upper respiratory tract against both RSV A and B strain infection and induced polyclonal palivizumab competing antibodies similar to but potentially more broadly protective against RSV than palivizumab." @default.
• W2014335798 created "2016-06-24" @default.
• W2014335798 creator A5000458556 @default.
• W2014335798 creator A5008188983 @default.
• W2014335798 creator A5008380917 @default.
• W2014335798 creator A5016994293 @default.
• W2014335798 creator A5032295889 @default.
• W2014335798 creator A5034630762 @default.
• W2014335798 creator A5052336708 @default.
• W2014335798 creator A5074981486 @default.
• W2014335798 creator A5091128747 @default.
• W2014335798 date "2014-11-01" @default.
• W2014335798 modified "2023-09-27" @default.
• W2014335798 title "An insect cell derived respiratory syncytial virus (RSV) F nanoparticle vaccine induces antigenic site II antibodies and protects against RSV challenge in cotton rats by active and passive immunization" @default.
• W2014335798 cites W1546655027 @default.
• W2014335798 cites W1547768824 @default.
• W2014335798 cites W1658519144 @default.
• W2014335798 cites W1894593978 @default.
• W2014335798 cites W1901508837 @default.
• W2014335798 cites W1974542809 @default.
• W2014335798 cites W1975386460 @default.
• W2014335798 cites W1984286626 @default.
• W2014335798 cites W1986189079 @default.
• W2014335798 cites W1989501142 @default.
• W2014335798 cites W1990295383 @default.
• W2014335798 cites W2001197069 @default.
• W2014335798 cites W2016383224 @default.
• W2014335798 cites W2019706667 @default.
• W2014335798 cites W2020830257 @default.
• W2014335798 cites W2022949657 @default.
• W2014335798 cites W2025040902 @default.
• W2014335798 cites W2026499179 @default.
• W2014335798 cites W2026510813 @default.
• W2014335798 cites W2026762686 @default.
• W2014335798 cites W2033882116 @default.
• W2014335798 cites W2034017940 @default.
• W2014335798 cites W2043056303 @default.
• W2014335798 cites W2046524042 @default.
• W2014335798 cites W2055333898 @default.
• W2014335798 cites W2068944472 @default.
• W2014335798 cites W2083637922 @default.
• W2014335798 cites W2093529351 @default.
• W2014335798 cites W2099904077 @default.
• W2014335798 cites W2102003227 @default.
• W2014335798 cites W2110547872 @default.
• W2014335798 cites W2113629675 @default.
• W2014335798 cites W2118919020 @default.
• W2014335798 cites W2121991462 @default.
• W2014335798 cites W2123817481 @default.
• W2014335798 cites W2133134586 @default.
• W2014335798 cites W2133963352 @default.
• W2014335798 cites W2139841187 @default.
• W2014335798 cites W2139907403 @default.
• W2014335798 cites W2140898182 @default.
• W2014335798 cites W2142073032 @default.
• W2014335798 cites W2161433430 @default.
• W2014335798 cites W2164992622 @default.
• W2014335798 cites W2169665123 @default.
• W2014335798 doi "https://doi.org/10.1016/j.vaccine.2014.09.030" @default.
• W2014335798 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7172787" @default.
• W2014335798 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25269094" @default.
• W2014335798 hasPublicationYear "2014" @default.
• W2014335798 type Work @default.
• W2014335798 sameAs 2014335798 @default.
• W2014335798 citedByCount "62" @default.
• W2014335798 countsByYear W20143357982015 @default.
• W2014335798 countsByYear W20143357982016 @default.
• W2014335798 countsByYear W20143357982017 @default.
• W2014335798 countsByYear W20143357982018 @default.
• W2014335798 countsByYear W20143357982019 @default.
• W2014335798 countsByYear W20143357982020 @default.
• W2014335798 countsByYear W20143357982021 @default.
• W2014335798 countsByYear W20143357982022 @default.
• W2014335798 countsByYear W20143357982023 @default.
• W2014335798 crossrefType "journal-article" @default.
• W2014335798 hasAuthorship W2014335798A5000458556 @default.
• W2014335798 hasAuthorship W2014335798A5008188983 @default.
• W2014335798 hasAuthorship W2014335798A5008380917 @default.
• W2014335798 hasAuthorship W2014335798A5016994293 @default.
• W2014335798 hasAuthorship W2014335798A5032295889 @default.
• W2014335798 hasAuthorship W2014335798A5034630762 @default.
• W2014335798 hasAuthorship W2014335798A5052336708 @default.
• W2014335798 hasAuthorship W2014335798A5074981486 @default.
• W2014335798 hasAuthorship W2014335798A5091128747 @default.
• W2014335798 hasBestOaLocation W20143357981 @default.
• W2014335798 hasConcept C147483822 @default.
• W2014335798 hasConcept C159047783 @default.
• W2014335798 hasConcept C159654299 @default.
• W2014335798 hasConcept C203014093 @default.
• W2014335798 hasConcept C2522874641 @default.
• W2014335798 hasConcept C2777863537 @default.
• W2014335798 hasConcept C2778644256 @default.
• W2014335798 hasConcept C2778668663 @default.
• W2014335798 hasConcept C2778943623 @default.
• W2014335798 hasConcept C2779341262 @default.
• W2014335798 hasConcept C2779702909 @default.
• W2014335798 hasConcept C2780801004 @default.
• W2014335798 hasConcept C2780868878 @default.

• next